Tumour resistance to cisplatin: A modelling approach

Physics in Medicine and Biology

Volumn 50, Issue 1, 2005, Pages 93-102

  Marcu, L ^a,b   Bezak, E ^a,b   Olver, I ^a,b   van Doorn, T ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CHEMOTHERAPY; DRUG DOSAGE; ONCOLOGY; PHARMACOKINETICS;

CISPLATIN; DRUG RESISTANCE; HAEMATOLOGICAL TUMORS; STEM CELLS;

TUMORS;

CISPLATIN;

APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; CYTOTOXICITY; DNA ADDUCT; GROWTH RATE; HEAD AND NECK CARCINOMA; MONTE CARLO METHOD; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR CELL; TUMOR GROWTH;

ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; CELL SURVIVAL; CISPLATIN; DNA ADDUCTS; DRUG RESISTANCE; DRUG RESISTANCE, NEOPLASM; HUMANS; KINETICS; MODELS, STATISTICAL; MONTE CARLO METHOD; NEOPLASMS; NORMAL DISTRIBUTION; STEM CELLS; TIME FACTORS;

EID: 13244281830     PISSN: 00319155     EISSN: None     Source Type: Journal    
DOI: 10.1088/0031-9155/50/1/008     Document Type: Article

References (17)

1. Andrews P A and Howell S B 1990 Cellular pharmacology of cisplatin, perspectives on mechanisms of acquired resistance Cancer Cells 2 35
2. Dewit L 1987 Combined treatment of radiation and cis-diamminedichloroplatinum (II): a review of experimental and clinical data Int. J. Radiat. Oncol. Biol. Phys. 13 403-26
3. Douple E B and Richmond R C 1979 A review of platinum complex biochemistry suggests a rationale for combined platinum-radiotherapy Int. J. Radiat. Oncol. Biol. Phys. 5 1335-9
4. Eastman A 1987 The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes Pharmacol. Ther. 34 155-66
5. Goldie J H and Coldman A J 1979 A mathematic model for relating the drug sensitivity of tumours to their spontaneous mutation rate Cancer Treat. Rep. 63 1727-33
6. Jeremic B et al 2000 Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial J. Clin. Oncol. 18 1458-64
7. Marcu L, van Doorn T and Olver I 2003 Cisplatin and radiotherapy in the treatment of locally advanced head and neck cancer Acta Oncol. 42 315-25
8. Marcu L, van Doorn T, Zavgorodni S and Olver I 2002 Growth of a virtual tumour using probabilistic methods of cells generation Australas. Phys. Eng. Sci. Med. 25 155-61
9. Oldenburg J et al 1994 Characterization of resistance mechanisms to cis-diamminedichloroplatinum (II) in three sublines of the CC531 adenocarcinoma cell line in vitro Cancer Res. 54 487-93
10. Ormerod M G et al 1996 cis-Diamminedichloroplatinum(II)-induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell lines Cancer Chemother. Pharmacol. 37 463-71
11. Schwachöfer J H M, Crooijmans R P, Hoogenhout J, Kal H B and Theeuwes A G M 1991 Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin: influence of treatment sequence Int. J. Radiat. Oncol. Biol. Phys. 20 1235-41
12. Sharma V M and Wilson W R 1999 Radiosensitization of advanced squamous cell carcinoma of the head and neck with cisplatin during concomitant radiation therapy Eur. Arch. Otorhinolaryngol. 256 462-5
13. Sorenson C M, Barry M A and Eastman A 1990 Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin J. Natl Cancer Inst. 82 749-55
14. Trimmer E E and Essigmann J M 1999 Cisplatin Essays Biochem. 34 191-211
15. Weldon T 1988 Mathematical Models in Cancer Research (Bristol and Philadelphia: Institute of Physics Publishing)
16. Welters, MJP et al 1997 Relationship between the parameters cellular differentiation, doubling time and platinum accumulation and cisplatin sensitivity in a panel of head and neck cancer cell lines Int. J. Cancer 71 410-5
17. Welters M J et al 1999 Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo Br. J. Cancer 79 82-88